Related by context. Frequent words. (Click for all words.) 64 Frank Condella 63 Richard J. Meelia 63 Frank Laukien 63 Joel F. Gemunder 62 Jerre Stead 61 David Bupp Neoprobe 61 Lonnie Moulder 61 Martin Gerstel 61 Paul Laikind 61 Robert Vrij 61 Arthur S. Przybyl 60 Jure Sola 60 Thomas CK Yuen 60 Faheem Hasnain 60 LGL Group 60 Olof Faxander 60 Paul Bisaro Watson 60 Roy Vallee Avnet 60 Juergen Engel Ph.D. 60 Alberto Weisser 60 Ralph Scozzafava 60 Martin Madaus 59 Stephen J. Gurgovits 59 Discusses Q3 59 David A. Daberko 59 Discusses Q4 59 ChiefExecutive Officer 59 Cerus Corporation 59 Marijn E. Dekkers 59 Cary Rayment 59 Ron Bentsur 58 Sequa Corporation 58 Nasdaq INCY announced 58 Barry D. Quart 58 Jeff Morhet 58 Marc Beuls 58 Neil K. Warma 58 Spiro Rombotis President 58 Pedro Lichtinger 58 PRAECIS PHARMACEUTICALS INCORPORATED 58 Syndax 58 Chief ExecutiveOfficer 58 Jeff Fettig Whirlpool 57 Mike Matysik 57 Scott V. Fainor 57 NASDAQ NOVN 57 Kevin T. Kabat 57 BioLife Solutions 57 C. Berenato 57 Altus Pharmaceuticals 57 Adopts #b# 1 57 David Aviezer 57 Gunnar Brock 57 Kleanthis G. Xanthopoulos Ph.D. 57 Chief FinancialOfficer 57 Clifford D. Nastas 57 Alexander Goncharuk 57 ALTANA AG 57 Roland Junck 57 Dr. Scangos 57 Bruce Carbonari 57 Salvatore D. Fazzolari 57 Simon Sturge 56 Kathryn V. Marinello 56 Sachiko Kuno Ph.D. 56 Jeffrey H. Buchalter 56 Jiangbo Pharmaceuticals 56 Eamonn Hobbs 56 Steven Laub 56 Arthur Bedrosian president 56 Frank A. Lodzinski 56 Dean Foate 56 Transcept Pharmaceuticals 56 Eric Krasnoff 56 Evaluate Strategic Alternatives 56 Keijo Suila 56 Kevin Hrusovsky 56 Sinks Lower 56 Keith D. Nosbusch 56 Raymond J. Milchovich 56 Clint Severson 56 OmniComm Systems 56 Jai Nagarkatti 56 Roger Boissonneault 56 Lantibio 56 Pierre Brondeau 56 Moncef Slaoui 56 Xenogen Corporation 56 InKine Pharmaceutical Company 56 MultiCell Technologies 56 XTLbio 56 Brian Markison 55 EDAP TMS 55 Brian Swette 55 Igeneon 55 Fred Kornberg 55 Thomas R. Watjen 55 Ron Najafi 55 Endures Analyst Downgrade 55 Elmar Schnee 55 Carl A. Pelzel